Transitional cell carcinoma in renal transplant recipients

World Journal of Surgery

Volumn 27, Issue 8, 2003, Pages 912-916

  Kao, Yu Lin ^a,b   Ou, Yen Chuan ^a,b   Yang, Chi Rei ^a,c   Ho, Hao Chung ^a,b   Su, Chung Kuang ^a,b   Shu, Kuo Hsiung ^a,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CISPLATIN; CYCLOSPORIN A; EPIRUBICIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MITOMYCIN C; STEROID;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; FEMALE; HUMAN; ILEAL CONDUIT; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; RETROGRADE PYELOGRAPHY; STEROID THERAPY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINARY DIVERSION;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; UROLOGIC NEOPLASMS;

EID: 0042326278     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-6954-3     Document Type: Article

References (18)

1. Penn I. Malignancy. Surg. Clin. North Am. 1994;74:1247-1257
2. Penn I. Cancer following cyclosporine therapy. Transplantation 1987;43:32-35
3. Blohme I, Brynger H. Malignant disease in renal transplant patients. Transplantation 1985;39:23-25
4. Sheil AGR. Cancer after transplantation. World J. Surg. 1986;10:389-396
5. Vogt P, Frei U, Repp H, et al. Malignant tumor in renal transplant recipients receiving cyclosporine: survey of 598 first-kidney transplantations. Nephrol. Dial. Transplant. 1990;5:282-288
6. Yang TC, Shu KH, Cheng CH, et al. Malignancy following renal-transplantation. Chin. Med. J. 1998;61:281-288
7. Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer 1999;85:1342-1344
8. Lee SH, Lin JSN, Tzai TS, et al. Prognostic factors of primary transitional cell carcinoma of upper urinary tract. Eur. Urol. 1996;29:266-270
9. Hsieh YF, Ling GC, Lu YB, et al. Incidence of tumor of renal pelvis in Taiwan. J. Formos. Med. Assoc. 1979;78:749-753
10. Colombo T, Zigeuner R, Zitta S, et al. Orthotopic neobladder in a woman after kidney transplantation. J. Urol. 1997;158:2236-2237
11. Giessing M, Türk I, Schoenberger B, et al. Orthotopic neobladder after kidney transplantation in a male patient with recurring urothelial carcinoma and renal cancer. J. Urol. 2001;166:1383
12. Swindle P, Falk M, Rigby R, et al. Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics. Br. J. Urol. 1998;81:229-233
13. Detrovic UJ, Bukurov NS, Djokic MR, et al. Balkan endemic nephropathy and papillary transitional cell tumors of the renal pelvis and ureters. Kidney Int. 1991;40:S77-S99
14. Cosyns JP, Jadoul M, Aquifflet JP, et al. Urothelial malignancy in Chinese herbs nephropathy. Lancet 1994;344:188
15. Penn I. The problem of cancer in organ transplant recipients: an overview. Transplant. Sci. 1994;4:23-32
16. Yang CC, Rohr MC, Assimos DG. Pretransplant urologic evaluation. Urology 1994;43:169-173
17. Penn I. Primary kidney tumors before and after renal transplantation. Transplant 1995;59:480-485
18. Benisovich VI, Silverman L, Slifkin R, et al. Cisplatin-based chemotherapy in renal transplant recipients. Cancer 1996;77:160-163